The Federal Trade Commission is investigating Amazon’s $3.9 billion acquisition of the first well being group One Medical, a transfer that would delay the completion of the deal.
Both One Medical and Amazon acquired a request for extra info Friday in reference to an FTC evaluation of the merger, in accordance with a submitting made with securities regulators by One Medical’s mum or dad, San Francisco-based 1Life Healthcare Inc.
Amazon introduced plans in late July to purchase One Medical, a concierge-type medical service with roughly 190 medical places of work in 25 markets. Last week, the e-commerce large stated it might shutter its personal hybrid digital in-home care service known as Amazon Care, a One Medical competitor, as a result of it wasn’t assembly clients’ wants.
The One Medical deal, the primary to be introduced below CEO Andy Jassy, was one other push into healthcare for Amazon following its acquisition of the net pharmacy PillPack for $750 million in 2018. Groups calling for stricter antitrust laws shortly urged the FTC to dam the merger, arguing it might additional develop the company‘s large market energy.
An Amazon spokesperson declined to remark.
The FTC has already been investigating the sign-up and cancellation practices of Amazon Prime and has issued civil subpoenas in that case.
Last yr, the corporate requested unsuccessfully that FTC Chair Lina Khan step except for separate antitrust investigations into its enterprise, arguing she could be biased. Khan was notable critic of Seattle-based Amazon and different Big Tech firms previous to assuming the chairmanship. As a Yale legislation pupil in 2017, she wrote an influential research titled “Amazon’s Antitrust Paradox.”
© 2022 The Associated Press. All rights reserved. This materials might not be revealed, broadcast, rewritten or redistributed with out permission.
FTC investigating Amazon’s $3.9B buy of One Medical (2022, September 3)
retrieved 3 September 2022
This doc is topic to copyright. Apart from any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.